Bentham Science Logo
Journal Cover

Track Your Manuscript:


Recent Patents on Anti-Cancer Drug Discovery

Volume 16, 4 Issues, 2021
ISSN: 2212-3970 (Online)
ISSN: 1574-8928 (Print)
This journal supports open access

Aims & Scope

Recent Patents on Anti-Cancer Drug Discovery publishes review/mini review and research articles that reflect or deal with studies in relation to a patent, application of reported patents in a study, discussion of comparison of results regarding application of a given patent, etc., and also guest edited thematic issues on recent patents in the field of anti-cancer drug discovery e.g. on novel bioactive compounds, analogs, targets & predictive biomarkers & drug efficacy biomarkers. The journal also publishes book reviews of eBooks and books on anti-cancer drug discovery. A selection of important and recent patents on anti-cancer drug discovery is also included in the journal. The journal is essential reading for all researchers involved in anti-cancer drug design and discovery. The journal also covers recent research (where patents have been registered) in fast emerging therapeutic areas/targets & therapeutic agents related to anti-cancer drug discovery.

Recent Patents on Anti-Cancer Drug Discovery

,

Volume 16

-

Number 2











Review Article

Repurposing of Metformin for Cancer Therapy: Updated Patent and Literature Review

, 16(2): 161 - 186

Zainab Sabry Othman Ahmed, Matthew Golovoy, Yassen Abdullah, Reda Saber Ibrahim Ahmed and Q. Ping Dou*


DOI: 10.2174/1574892816666210615163417






General Review Article

Natural Product as Substrates of ABC Transporters: A Review

, 16(2): 222 - 238

Xuan-Yu Chen, Jing-Quan Wang, Yuqi Yang, Jing Li* and Zhe-Sheng Chen*


DOI: 10.2174/1574892816666210218220943


Articles Ahead of Print

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer


Yuao Deng*, Longyang Liu*, Weifeng Feng*, Zhongqiu Lin, Yingxia Ning and Xin Luo


DOI: 10.2174/1574891X16666210706153740
View Abstract



Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review


Debasmita Mukhopadhyay, Catherine Sano, Nour AlSawaftah, Rafat El-Awadi, Ghaleb A. Husseini* and Vinod Paul


DOI: 10.2174/1574892816666210706155110
View Abstract



Study on the Anti-Tumor Mechanism and Target of Triptolide based on Network Pharmacology and Molecular Docking


Tao Zou, Yuanqiong Huang, Yifan Hu, Mingyu Wu, Yueshui Zhao, Fukuan Du, Mingxing Li, Xu Wu, Huijiao Ji, Parham Jabbarzadeh Kaboli, Shurong Wang, Zhangang Xiao* and Zhigui Wu*


DOI: 10.2174/1574892816666210211143059
View Abstract View on PubMed





STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells


Yao Liu, Xiaolin Peng, Hui Li, Wenhui Jiao, Xin Peng, Jingrong Shao, Yanglu Xu, Ran Wang*, Wei Wang* and Dexin Kong*


DOI: 10.2174/1574892816666210224155403
View Abstract View on PubMed


Human Saliva Metabolome for Oral Lichen Planus Biomarker Identification


Xiaoshuang Wang, Liwei Liu, Qiuzheng Du, Zhi Sun, Erli Yue, Peng Xue* and Hongyu Zhao*


DOI: 10.2174/1574892816666210224160120
View Abstract View on PubMed


Abstracts Ahead of Print



Rho GTPase Activating Protein 9 (ARHGAP9) in Human Cancers


Wenping Song, Jinhua Chen, Shuolei Li, Ding Li, Yongna Zhang, Hanqiong Zhou, Weijiang Yu, Baoxia He, Wenzhou Zhang* and Liang Li*


DOI: 10.2174/1574892816666210806155754
View Abstract




Circular RNA NF1-419 Inhibits Proliferation and Induces Apoptosis by Regulating Lipid Metabolism in Astroglioma Cells


Ran Li, Xiaocui Tang, Changqiong Xu, Yinrui Guo, Longkai Qi, Shan Li, Qiuyun Ren, Jie Wu* and Diling Chen*


DOI: 10.2174/1574892816666210729125802
View Abstract



Artificial Intelligence and Cancer Drug Development


Fan Yang, Jerry D. Darsey, Anindya Ghosh, Hong-Yu Li, Mary Q. Yang and Shanzhi Wang*


DOI: 10.2174/1574892816666210728123758
View Abstract



The validity of mobile applications to facilitate patient care provided to cancer patients: opportunities and limitations


Haneen Amawi*, Sayer Alazzam, Tasnim Alzanati , Neveen Altamimi, Alaa Hammad , Karem H. Alzoubi , Jr. Charles R. Ashby and Amit K. Tiwari


DOI: 10.2174/1574892816666210728122304
View Abstract


Published Contents

Editor's Choice





Feasibility of Repurposing Clioquinol for Cancer Therapy

, 2020; 15(1): 14 - 31

Raheel Khan, Harras Khan, Yassen Abdullah and Q. Ping Dou*


DOI: 10.2174/1574892815666200227090259




HMGA and Cancer: A Review on Patent Literatures

, 2019; 14(3): 258 - 267

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827



PARP Inhibitors in Ovarian Cancer

, 2018; 13(4): 392 - 410

Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*


DOI: 10.2174/1574892813666180305165256



Open Access Articles

Next Generation Sequencing in the Management of Leptomeningeal Metastases of Non-Small Cell Lung Cancer: A Case Report and Literature Review

, 2021; 16(1): 108 - 116

Shuo Li*, Linping Ke*, Xue Meng, Haiyan Zhou, Xiqin Zhang, Huaguo Wu, Jinming Yu* and Hui Zhang*





From Antimicrobial to Anticancer Peptides: The Transformation of Peptides

, 2019; 14(1): 70 - 84

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*





New Anti-Cancer Strategies in Testicular Germ Cell Tumors

, 2019; 14(1): 53 - 59

Paolo Chieffi*, Marco De Martino and Francesco Esposito




Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents

, 2019; 14(1): 5 - 18

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*




Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer

, 2019; 14(1): 39 - 52

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*




Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment

, 2019; 14(1): 32 - 38

Giorgia Scarpellino, Tullio Genova and Luca Munaron*




Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds

, 2019; 14(1): 19 - 31

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*




Semi-Synthetic Derivatives of Heliomycin with an Antiproliferative Potency

, 2018; 13(4): 469 - 472

Georgy Y. Nadysev, Alexander S. Tikhomirov, Lyubov G. Dezhenkova and Andrey E. Shchekotikhin*





Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature

, 2018; 13(4): 422 - 427

Sara Petrillo, Emanuela Tolosano, Luca Munaron and Tullio Genova*




Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options

, 2018; 13(2): 209 - 223

Theodosis Kalamatianos, Despoina Denekou, George Stranjalis and Evangelia Papadimitriou*




Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied

, 2018; 13(2): 201 - 208

Silvia M. Ferrari, Ilaria Ruffilli, Marco Centanni, Camilla Virili, Gabriele Materazzi, Magdalini Alexopoulou, Mario Miccoli, Alessandro Antonelli* and Poupak Fallahi




Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184 - 200

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*





Most Cited Articles

Review Article

Repurposing disulfiram as an anti-cancer agent: Updated review on literature and patents

, 2019; 14(2): 113-132.

Elmira Ekinci, Sagar Rohondia, Raheel Khan and Qingping P. Dou*


DOI: 10.2174/1574892814666190514104035


Review Article

Tobacco smoking: Risk to develop addiction, chronic obstructive pulmonary disease, and lung cancer

, 2019; 14(1): 39-52.

Alessia Santoro, Carlo Tomino, Giulia Prinzi, Palma Lamonaca, Vittorio Cardaci, Massimo Fini and Patrizia Russo*


DOI: 10.2174/1574892814666190102122848


Review Article

New anti-cancer strategies in testicular germ cell tumors

, 2019; 14(1): 53-59.

Paolo Chieffi*, Marco De Martino and Francesco Esposito


DOI: 10.2174/1574892814666190111120023


General Review Article

HMGA and cancer: A review on patent literatures

, 2019; 14(3): 258-267.

Marco De Martino, Alfredo Fusco and Francesco Esposito*


DOI: 10.2174/1574892814666190919152001


Review Article

Cucurbitacins as anticancer agents: A patent review

, 2019; 14(2): 133-143.

Hidayat Hussain*, Ivan R. Green, Muhammad Saleem, Khanzadi F. Khattak, Muhammad Irshad and Maroof Ali


DOI: 10.2174/1574892813666181119123035


Research Article

A truncated snail1 transcription factor alters the expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line

, 2019; 14(2): 158-169.

Mohammad Davoodzadeh Gholami, Reza Falak*, Sahel Heidari, Majid Khoshmirsafa, Mohammad H. Kazemi, Amir-Hassan Zarnani, Elaheh Safari, Nader Tajik and Gholam A. Kardar*


DOI: 10.2174/1574892814666190527111429



Review Article

Contemporary formulations for drug delivery of anticancer bioactive compounds

, 2019; 14(1): 19-31.

Darinka G. Ackova, Katarina Smilkov and Darko Bosnakovski*


DOI: 10.2174/1574892814666190111104834


Review Article

Tocotrienols and cancer: From the state of the art to promising novel patents

, 2019; 14(1): 5-18.

Fabrizio Fontana, Michela Raimondi, Monica Marzagalli, Roberta M. Moretti, Marina Montagnani Marelli and Patrizia Limonta*


DOI: 10.2174/1574892814666190116111827


Review Article

From antimicrobial to anticancer peptides: The transformation of peptides

, 2019; 14(1): 70-84.

Yuan Qin, Zuo D. Qin, Jing Chen, Che G. Cai, Ling Li, Lu Y. Feng, Zheng Wang, Gregory J. Duns, Nong Y. He, Zhe S. Chen* and Xiao F. Luo*


DOI: 10.2174/1574892814666190119165157


Review Article

MDM2-P53 interaction inhibitors: The current state-of-art and updated patent review (2010-present)

, 2019; 14(4): 324-369.

Rafał Rusiecki, Jakub Witkowski* and Jaszczewska-Adamczak Joanna


DOI: 10.2174/1574892814666191022163540



Review Article (Mini-Review)

Alkaloids as anticancer agents: A review of chinese patents in recent 5 years

, 2020; 15(1): 2-13.

Hongyu Tao, Ling Zuo, Huanli Xu, Cong Li, Gan Qiao, Mingyue Guo and Xiukun Lin*


DOI: 10.2174/1574892815666200131120618


Review Article

Purinergic P2X7 receptor: A cation channel sensitive to tumor microenvironment

, 2019; 14(1): 32-38.

Giorgia Scarpellino, Tullio Genova and Luca Munaron*


DOI: 10.2174/1574892814666190116122256




Most Accessed Articles




Natural Product as Substrates of ABC Transporters: A Review

, 2021; 16(2): 222-238.

Xuan-Yu Chen, Jing-Quan Wang, Yuqi Yang, Jing Li* and Zhe-Sheng Chen*


DOI: 10.2174/1574892816666210218220943




Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer

, 2021; 16(2): 273-284.

Babatomiwa Kikiowo*, Adewale J. Ogunleye, Opeyemi Iwaloye, Taiwo T. Ijatuyi, Niyi S. Adelakun and Wasiu O. Alashe


DOI: 10.2174/1574892816666210201115359












Editor-in-Chief

graphic
Zhe-Sheng (Jason) Chen
Institute for Biotechnology
College of Pharmacy and Health Sciences
St. John's University
New York, NY
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Recent Patents on Anti-Cancer Drug Discovery was launched in 2006. Prof. Zhe-Sheng (Jason) Chen serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog